News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
REMEGEN Continues Rally, Hitting 2-Yr High w/ ~5% Surge; Nomura Lifts TP on Shr Placement Aiming to Raise ~HKD800M
REMEGEN (09995.HK) announced before market open yesterday (22nd) a share placement at a 9.5% discount, aiming to raise net proceeds of HKD796 million.After surging by over 5% yeste...
Reset
Send
The window will close in 5 seconds
REMEGEN Continues Rally, Hitting 2-Yr High w/ ~5% Surge; Nomura Lifts TP on Shr Placement Aiming to Raise ~HKD800M
Close
Recommend
2
Positive
6
Negative
0
 
 

REMEGEN (09995.HK)  +1.750 (+3.539%)    Short selling $51.58M; Ratio 7.857%   announced before market open yesterday (22nd) a share placement at a 9.5% discount, aiming to raise net proceeds of HKD796 million.

After surging by over 5% yesterday, REMEGEN opened 0.3% lower this morning but managed a rebound afterward. It last traded at HKD51.85, up 4.85%, marking a new two-year high, on a volume of 4.221 million shares, involving HKD215 million.

REMEGEN is placing 19 million H-shares (representing about 3.37% of the enlarged share capital) at HKD42.44 per share, around a 9.51% discount to the previous day's (21st) closing price of HKD46.9. The net proceeds of around HKD796 million are intended to be used by the group to invest in R&D of its core product, Telitacicept (RC18), for the expansion of its core indications such as Myasthenia Gravis and Membranous Nephritis, and for general corporate purposes.

Nomura opined in its research report that the share placement was beneficial to REMEGEN's financial position, as financial issues have long been its major burden. The broker elevated its target price for the company from HKD16.37 to HKD47.6, with a Neutral rating remaining in place.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-23 16:25.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.